Work

CDK4/6 inhibitor in combination with aromatase inhibitor effective in metastatic hidradenocarcinoma

Year: 2025
Type: article
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,480
OpenAlex ID: W4409806777
FWCI: 0.797
Cites: 6
Cited by: 1
Related to: 10